Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 12-2012 | 03-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 1,550 | 0 | 343,974 | 524,901 |
| Marketable Securities | N/A | 0 | 0 | 669,997 | 393,837 |
| Receivables | N/A | 0 | 0 | 226,763 | 188,422 |
| Inventories | N/A | 0 | 0 | 225,838 | 213,869 |
| Other current assets | 0 | 250 | 0 | 87,468 | 88,110 |
| TOTAL | $N/A | $1,800 | $0 | $1,554,040 | $1,409,139 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,510 | N/A | 752,148 | 773,163 |
| Investments And Advances | 0 | 0 | 0 | 46,460 | 42,890 |
| Other Non-Current Assets | 0 | 2,150 | 0 | 267,930 | 275,830 |
| TOTAL | $N/A | $3,660 | $N/A | $1,066,538 | $1,091,883 |
| Total Assets | $N/A | $4,130 | $0 | $2,074,918 | $1,936,635 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 273,070 | 0 |
| Accounts payable and accrued liabilities | 0 | 670 | 0 | 87,380 | 51,190 |
| Accrued Expenses | N/A | 1,340 | 0 | 68,810 | 159,500 |
| Other current liabilities | N/A | 0 | 0 | 82,470 | 15,990 |
| TOTAL | $N/A | $4,010 | $0 | $518,099 | $232,231 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 13,340 | 0 | 106,048 | 103,189 |
| Other Non-Current Liabilities | 0 | 260 | 0 | 530,690 | 377,590 |
| TOTAL | $N/A | $13,600 | $N/A | $755,588 | $603,859 |
| Total Liabilities | $N/A | $17,620 | $0 | $1,273,696 | $836,105 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 0 | 0 | 949,240 | 1,293,810 |
| Retained earnings | N/A | -110,980 | 0 | -147,443 | -191,031 |
| Other shareholders' equity | 0 | 77,800 | 0 | -575 | -2,249 |
| TOTAL | $N/A | $-13,490 | $0 | $801,222 | $1,100,530 |
| Total Liabilities And Equity | $0 | $4,130 | $0 | $2,074,918 | $1,936,635 |